Aug. 15, 2024
FOR IMMEDIATE RELEASE
WASHINGTON, D.C. – We Work For Health Executive Director Dan Leonard issued the
following statement in response to the administration’s announcement today regarding
the results of the first prescription drugs in Medicare selected for price setting under the
Inflation Reduction Act (IRA):